Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
The SURPASS-CVOT trial is ongoing to evaluate cardiovascular outcomes, but preliminary evidence indicates improvements in cardiovascular risk factors including blood pressure and triglycerides
About 60% of GLP-1 users who experience gastrointestinal side effects report that nighttime injection significantly reduces their perception of nausea, simply because they sleep through the worst of it
Retrieved 6 April 2017
Reporting from STAT News also found the 2025 federal pricing deal carried an unpublicized condition: private Medicare insurers had to agree to cover GLP-1s broadly at the $50 copay in exchange for the discounted price, so plans implement the coverage differently and the broad retail price cuts many patients expected never arrived
US$ 29.62
US$ 21.71
US$ 20.39
US$ 25.76
US$ 20.28
US$ 20.18
US$ 20.02
US$ 26.56
US$ 26.98
